European Research Organisation on Genital Infection and Neoplasia (EUROGIN) Congress 2017
Amsterdam RAI Exhibition and Convention CentreAmsterdam, NETHERLANDS Visit the Venue to read more
Dear friends and colleagues,
On behalf of the EUROGIN Organizing Committee, I am pleased to welcome you to the EUROGIN 2017 international congress.
As one of the most important conferences on human papillomavirus infection and related cancers, our event continues to foster multidisciplinary interactions that are vital to making critical discoveries. The high-ranking scientific committee includes members representing a wide range of interests and scientific expertise that are required to develop an outstanding meeting. The program also encompasses state-of-the art science on ano-genital and head & neck cancer, inspires collaboration, and provides forums to share expertise and learn from the leading experts in these fields.
The EUROGIN 2017 Congress aims at developing a full review of current scientific developments in the field of cancer and human papillomavirus related diseases, raising the public health profile and increasing the need for responsible health services in this area. The event endeavours to translate scientific and evidence-based research into clinical practice while highlighting the following aspects:
- Recent advances and updated scientific insights in HPV screening, testing and management
- The impact of HPV and associated cancers on public health
- Strategies to prevent and treat HPV related diseases- Exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination
Speakers include international leaders from academic, government and private organizations, representatives of medical and scientific societies, as well as women's health associations who will discuss and exchange ideas on issues relevant to both individuals and public health
The program has been planned and implemented according to UEMS criteria and an application for CME accreditation will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME).
The EUROGIN 2017 congress will offer excellent opportunities for learning and networking with professionals from many different disciplines. We hope that every conference attendee will take full advantage of the sessions offered: Training Courses, Oral Communications, Scientific and Main Scientific sessions, Clinical sessions, Poster presentations, and Satellite Symposia.
We look forward to welcome you at this stimulating and rewarding scientific event.
Chairman of the Scientific Committee
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Amsterdam RAI Exhibition and Convention Centre
Amsterdam, Noord Holland, Netherlands
In the online process you will first need to create a “Submitter Account”.
Following the creation of the submitter account you will receive an email with your personal access code.
The submission process requires to identify the abstract submitter and the main author (this may be the same person or two different persons).
The system will allow you to start drafting the abstract and to work on it including interruptions, and to save it as often as you wish as a draft before eventually submitting the final version.
General Conditions for Submission of Abstracts
Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2017 Congress and that financial resources to attend are available;
Abstract presenters who would like to benefit from the early bird registration rate (deadline is April 3) are advised to submit their abstract before March 31 and send a short notice to email@example.com. They will then receive notification of acceptance/refusal which will allow them to register at the early bird rate
Authors are requested to register within 10 days after having received their provisional notification of acceptance. Abstracts of authors not registered by May 20, 2017 will not be taken into consideration for the final program.
Abstract presenters who would like to benefit from the early bird registration rate (deadline is April 3) are advised to submit their abstract before March 31 and send a short notice to firstname.lastname@example.org . They will then receive notification of acceptance/refusal which will allow them to register at the early bird rate.
If the abstract presenter is registered with a group, please inform the Congress Secretariat at: email@example.com and indicate the person who booked the group registration.
Abstracts must be submitted and presented in ENGLISH
Abstracts should be prepared in accordance to the instructions below and submitted through the online system. Abstracts should comply with the editing instructions;
For proffered papers (for Oral Communications sessions or Poster presentation), only ONE abstract is allowed per person duly registered for the congress;
Original scientific material is welcome and preference is given to recent findings not yet published at the date of the Congress;
Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation;
The final decision of the Scientific Committee will be announced before May 15, 2017;
Authors agree that their abstract will be published in the congress abstract book (pdf document, no printed document will be issued)
All accepted abstract submitters will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract, as well as the email addresses of the main author and the presenter (the author who will present the paper at the conference). The main author and the presenter can be the same person. They may also be identical to or different from the submitter);
The main author and the presenter must be identified (by ticking the corresponding boxes)
For further information and assistance please contact the scientific secretariat at firstname.lastname@example.org
Abstract Editing Instructions
Abstracts must be submitted through the online submission system;
Maximum length (body of abstract): 2700 characters;
The title should be written in UPPER CASE (capitals); (keep it as short as possible, clearly indicating the nature of the investigation. ;
Please avoid complex mathematical formulae; the system allows to insert simple tables.
Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned.
All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract.
Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;
Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;
Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;
Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;
Drugs must be identified by their generic names
Contact No.: +33 1 44 40 01 20
Contact No.: +33 1 44 40 01 20